|
End-of-day quote
Shenzhen S.E.
2026-10-23
|
5-day change | 1st Jan Change | ||
| 4.600 CNY | -0.22% |
|
+1.77% | +5.75% |
| Market Cap | 6.28B 941M 841M 777M 704M 1.32B 89.36B 1.34B 9.35B 3.7B 46.82B 3.53B 3.46B 148B | P/E 2024 |
193x | P/E 2025 | -54.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.15B 1.07B 958M 885M 802M 1.5B 102B 1.52B 10.65B 4.22B 53.34B 4.02B 3.94B 168B | EV / Sales 2024 |
1.74x | EV / Sales 2025 | 2.23x |
| Free-Float |
66.81% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.22% | ||
| 1 week | +1.77% | ||
| Current month | -1.92% | ||
| 1 month | -0.22% | ||
| 3 months | +4.31% | ||
| 6 months | -5.35% | ||
| Current year | +5.75% |
| 1 week | 4.48 |  | 4.64 |
| 1 month | 4.48 | | 4.77 |
| Current year | 4.08 | | 5.47 |
| 1 year | 4.08 | | 6.25 |
| 3 years | 2.98 | | 8.8 |
| 5 years | 2.98 | | 11.97 |
| 10 years | 2.98 | | 23.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Niu
CEO | Chief Executive Officer | 56 | 2015-04-01 |
Hong Xing Li
DFI | Director of Finance/CFO | 41 | 2020-12-28 |
Pei Chen
PRN | Corporate Officer/Principal | 42 | 2014-01-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Min Niu
CHM | Chairman | 56 | 2026-03-26 |
Yong Jiang
BRD | Director/Board Member | 58 | 2007-12-24 |
Pei Chen
BRD | Director/Board Member | 42 | 2014-01-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/21/20 | Sell | Chairman | 1,940,600 | 0.2495% | ||
| 9/18/20 | Sell | Director | 3,670,000 | 0.4719% | ||
| 9/18/20 | Sell | Chairman | 296,500 | 0.0381% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | +1.77% | -21.10% | -41.55% | 941M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -1.01% | +2.08% | +31.21% | +58.09% | 400.46B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.01% | +79.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.83B 574M 512M 473M 429M 802M 54.44B 815M 5.69B 2.25B 28.52B 2.15B 2.11B 89.93B | 3.05B 457M 408M 377M 342M 639M 43.39B 650M 4.54B 1.8B 22.73B 1.72B 1.68B 71.67B |
| Net income | 33.62M 5.04M 4.5M 4.16M 3.77M 7.05M 479M 7.17M 50.04M 19.81M 251M 18.92M 18.51M 790M | -104M -15.65M -13.97M -12.91M -11.7M -21.88M -1.49B -22.25M -155M -61.5M -778M -58.72M -57.47M -2.45B |
| Net Debt | 1.4B 210M 187M 173M 157M 294M 19.93B 298M 2.08B 825M 10.44B 788M 771M 32.92B | 875M 131M 117M 108M 98.03M 183M 12.45B 186M 1.3B 515M 6.52B 492M 482M 20.56B |
Employees
5,715
Sector
Pharmaceuticals
Calendar
Oct. 24
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | CN¥4.600 | -0.22% | 7,687,600 |
| 26-10-22 | CN¥4.610 | +0.22% | 5,256,800 |
| 26-10-21 | CN¥4.600 | +1.55% | 5,978,203 |
| 26-10-20 | CN¥4.530 | -0.22% | 3,408,420 |
| 26-10-19 | CN¥4.540 | +0.44% | 4,718,800 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002424 Stock
Select your edition
All financial news and data tailored to specific country editions
